Literature DB >> 11447185

Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

J Brieland1, D Essig, C Jackson, D Frank, D Loebenberg, F Menzel, B Arnold, B DiDomenico, R Hare.   

Abstract

Cytokine-mediated host defense against Candida glabrata infection was compared to that against C. albicans, using immunocompetent murine models of systemic candidiasis. The pathogenesis of infection was evaluated morphologically and by culture of target organs, while the kinetics of induction of cytokine mRNAs and corresponding proteins were determined in kidneys by real-time reverse transcription-PCR and cytokine-specific murine enzyme-linked immunosorbent assays, respectively. Systemic infection with C. glabrata resulted in a chronic, nonfatal infection with recovery of organisms from kidneys, while intravenous inoculation with C. albicans resulted in rapid mortality with logarithmic growth of organisms in kidneys and recovery of C. albicans from the spleen, liver, and lungs. Survival of C. glabrata-infected mice was associated with rapid induction of mRNAs and corresponding immunoreactive proteins for the proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha), interleukin-12 (IL-12), and gamma interferon (IFN-gamma) and the lack of induction of protein for the anti-inflammatory cytokine IL-10. In contrast, mortality in C. albicans-infected mice was associated with induction of mRNA and corresponding protein for IL-10 but delayed (i.e., TNF-alpha) or absent (i.e., IL-12 and IFN-gamma) induction of immunoreactive proinflammatory cytokines. Mice were subsequently treated with cytokine-specific neutralizing monoclonal antibodies (MAbs) to TNF-alpha, IL-12, or IFN-gamma, and the effect on growth of C. glabrata in kidneys was assessed. Neutralization of endogenous TNF-alpha resulted in a significant increase in C. glabrata organisms compared to similarly infected mice administered an isotype-matched control MAb, while neutralization of endogenous IL-12 or IFN-gamma had no significant effect on C. glabrata replication. These results demonstrate that in response to intravenous inoculation of C. glabrata, immunocompetent mice develop chronic nonfatal renal infections which are associated with rapid induction of the proinflammatory cytokines TNF-alpha, IL-12, and IFN-gamma. Furthermore, TNF-alpha plays a key role in host defense against systemic candidiasis caused by either C. glabrata or C. albicans, as the absence of endogenous TNF-alpha activity was associated with enhanced tissue burden in both infection models.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447185      PMCID: PMC98599          DOI: 10.1128/IAI.69.8.5046-5055.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  84 in total

1.  Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans.

Authors:  L Romani; P Puccetti; A Mencacci; E Cenci; R Spaccapelo; L Tonnetti; U Grohmann; F Bistoni
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

Review 2.  Interactions of phagocytic cells with Candida and other opportunistic fungi.

Authors:  R D Diamond
Journal:  Arch Med Res       Date:  1993       Impact factor: 2.235

Review 3.  A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

Authors:  P Puccetti; L Romani; F Bistoni
Journal:  Trends Microbiol       Date:  1995-06       Impact factor: 17.079

4.  Cure of murine candidiasis by recombinant soluble interleukin-4 receptor.

Authors:  P Puccetti; A Mencacci; E Cenci; R Spaccapelo; P Mosci; K H Enssle; L Romani; F Bistoni
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

5.  Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis.

Authors:  Q Qian; M A Jutila; N Van Rooijen; J E Cutler
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

6.  Evidence implicating phospholipase as a virulence factor of Candida albicans.

Authors:  A S Ibrahim; F Mirbod; S G Filler; Y Banno; G T Cole; Y Kitajima; J E Edwards; Y Nozawa; M A Ghannoum
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

Review 7.  Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

8.  Heterogeneous secretory response of phagocytes from different anatomical districts to the dimorphic fungus Candida albicans.

Authors:  E Blasi; M Puliti; L Pitzurra; A Bartoli; F Bistoni
Journal:  Cell Immunol       Date:  1994-01       Impact factor: 4.868

9.  Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis.

Authors:  A Louie; A L Baltch; R P Smith; M A Franke; W J Ritz; J K Singh; M A Gordon
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.

Authors:  L Ozmen; M Pericin; J Hakimi; R A Chizzonite; M Wysocka; G Trinchieri; M Gately; G Garotta
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  54 in total

1.  Synthesis of melanin pigment by Candida albicans in vitro and during infection.

Authors:  Rachael Morris-Jones; Beatriz L Gomez; Soraya Diez; Martha Uran; Stephen D Morris-Jones; Arturo Casadevall; Joshua D Nosanchuk; Andrew J Hamilton
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

3.  A murine model for disseminated candidiasis in neonates.

Authors:  Nancy Y Tsai; Sonia S Laforce-Nesbitt; Richard Tucker; Joseph M Bliss
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

4.  NK cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis.

Authors:  José Juan Gaforio; Elena Ortega; Ignacio Algarra; María José Serrano; Gerardo Alvarez de Cienfuegos
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Authors:  Evelyn E Nash; Brian M Peters; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

6.  Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy.

Authors:  I D Jacobsen; S Brunke; K Seider; T Schwarzmüller; A Firon; C d'Enfért; K Kuchler; B Hube
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

7.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 8.  IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Authors:  Robert B Ashman; Dipti Vijayan; Christine A Wells
Journal:  Clin Dev Immunol       Date:  2010-11-01

9.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

10.  Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.

Authors:  Sélène Ferrari; Françoise Ischer; David Calabrese; Brunella Posteraro; Maurizio Sanguinetti; Giovanni Fadda; Bettina Rohde; Christopher Bauser; Oliver Bader; Dominique Sanglard
Journal:  PLoS Pathog       Date:  2009-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.